<?xml version="1.0" encoding="UTF-8"?>
<p>Patients were clinically evaluated for evidence of acute or delayed infusion‚Äêrelated adverse events. Vital signs, pulmonary function test results, and Borg Dyspnea Index recorded before and after infusion of MSCs are summarized in Table 
 <xref rid="sct312264-tbl-0004" ref-type="table-wrap">4</xref>. No significant changes were observed in heart rate, mean blood pressure, respiratory rate, O
 <sub>2</sub> saturation, or perceived dyspnea at 30, 60, and 120 minutes after MSC infusion compared with baseline values (individual changes in each patient are available in appendix tables (Supporting Information Tables 
 <xref rid="sct312264-tbl-0003" ref-type="table-wrap">3</xref>, 
 <xref rid="sct312264-tbl-0004" ref-type="table-wrap">4</xref>, 
 <xref rid="sct312264-tbl-0005" ref-type="table-wrap">5</xref>, 
 <xref rid="sct312264-tbl-0006" ref-type="table-wrap">6</xref>)).
</p>
